Risk factor
Resilient to price shocks
Profitability factor
Very low or no dividends
About
Operating within China, Guizhou Bailing Group Pharmaceutical Co., Ltd. specializes in the full spectrum of activities for traditional Chinese medicine, from initial research and development to manufacturing and market distribution. The company provides a diverse portfolio of medicinal preparations, available in numerous forms including tablets, capsules, granules, liquid syrups, pills, powdered formulations, tinctures, sprays, and topical ointments. These remedies are formulated to address a wide range of health concerns, such as cardiovascular and cerebrovascular conditions, common respiratory issues like coughs and colds, and specific pediatric and gynecological disorders. Established in 2005, its primary operational base is situated in Anshun, China.
Company Valuation
Considering past and projected metrics, the stock is moderately 'expensive' compared to its peers. Specifically, the stock is overvalued on EV/EBITDA, reasonably priced o